Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation - Wikidata - awgldk - TriplyDB

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

http://www.wikidata.org/entity/Q34079631

about

An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.Prediction of BOS by the single-breath nitrogen test in double lung transplant recipients.Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation Antibody-Mediated Lung Transplant Rejection HLA class I: an unexpected role in integrin β4 signaling in endothelial cells Lung Transplantation in Cystic Fibrosis: Trends and Controversies.Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?The clinical impact of humoral immunity in pediatric renal transplantation.Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.Impaired Capacity of Fibroblasts to Support Airway Epithelial Progenitors in Bronchiolitis Obliterans Syndrome Acute antibody-mediated rejection after lung transplantation.Antibody-mediated Rejection in Lung Transplantation.Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.Chronic lung allograft dysfunction after lung transplantation: the moving target.Immune responses to self-antigens (autoimmunity) in allograft rejection.Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Immunosuppression and allograft rejection following lung transplantation: evidence to date.Immunosuppression in lung transplantation.Lung transplant immunosuppression - time for a new approach?Transplantation tolerance; myth or reality?Current views on chronic rejection after lung transplantation.Comprehensive Care of the Lung Transplant Patient.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation.De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.A severe Mycoplasma pneumoniae pneumonia inducing an acute antibody-mediated pulmonary graft rejection.Chronic lung allograft dysfunction phenotypes and treatment.Acute allograft rejection: cellular and humoral processes.T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.Update on Chronic Lung Allograft Dysfunction.Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses.IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation.

P2860

Q26827623-E3DAEE0F-D446-4C2C-AA49-7F820C2EA8C4 Q33437712-3B0B4224-87B5-435A-8DF5-AFB972E7BFBF Q34036197-13AFC434-2E22-4406-9700-0F3CEBB88C51 Q34084066-3896F547-5DD6-4FF2-94B5-7A66FE02927C Q36131035-A23F0E26-8A8A-4778-AC18-2957C2061307 Q36243057-950DE0BC-7EEC-4F1B-B37C-5DEB6217F96E Q36360674-474A9DC3-215E-4996-ACBF-33B62FD96E38 Q36388454-839D2945-F6DF-44F7-8F9A-5EEBD08C322C Q36703898-9BAEBB93-16D9-4369-A8BE-5581AB30B8FC Q36719246-E8F37363-5D1F-4783-85D5-C59E5D90C0D7 Q36999202-EDD09243-9BE3-4FFD-AE87-65FA2A3387F3 Q37149537-C8DF7C1A-4764-4135-8352-979C0932B942 Q37228474-4F9130B7-E0DE-412C-9C7A-CEB624B2CB12 Q37294400-12FF5FAD-71B0-47E6-BA4E-0BF33575B691 Q37441785-36AE11DE-837F-41D7-9013-1F89F0554BD1 Q37528715-04B5915E-7986-4450-9CF1-D4CB1F732F29 Q37667779-722D0F0F-FF18-41ED-A07A-BA85C1DB2E70 Q37827197-E05E11D0-10B3-46BE-9B2D-B4B8AAC360A9 Q38053174-40602BEF-8112-41AE-931A-E23376BF66C3 Q38058746-7B562201-28A3-480F-86F3-2196CD9F4F72 Q38110566-4D377DDF-FB0B-491E-B5EB-63FBEDD3D733 Q38123309-B3400849-A152-48B7-BCBA-B038A04C9617 Q38154197-E1EA24B3-2840-4C88-B2EC-700FEEDC3A28 Q38240865-463FE346-17F7-4A01-B438-70B8BDE27AB5 Q38249128-70689599-FCAA-4416-BD7C-81F0FF8E9C22 Q38305297-4B4AEECA-AEC4-4183-B191-AD99B4762505 Q38413323-0883EB33-5191-4B43-BD4D-9D7E5385C020 Q38978203-EDB770FB-4ADF-491E-A434-9BB9474AAE5B Q39366396-CAFE37D7-3581-483B-B69D-1BAA9D11784A Q39402829-381557B5-4473-43AF-BF8B-2B483570BBCE Q39928595-F92C1624-7EFF-4381-87DF-04DC3E53DE19 Q40071041-D4F07DE1-AEE8-4BD2-9038-1823E9705FEE Q41303108-C423693F-BA74-4C65-B2B6-57E204D7CE78 Q41953105-2AABCB07-A095-4E49-9577-06B06D8BED80 Q41966454-036BAD48-9855-496D-AEC8-EF4E2974C834 Q41975571-ABBA2726-A302-421F-A1E4-7DD4335C3804 Q42324374-14CA29A2-68F3-4D21-B9FD-49349446202D Q42364236-A2EEB6A2-8690-4DA2-BC79-A49DBD1E4C74 Q42424933-7CF01052-99C9-4EFC-A02B-487C2FBF2046 Q42700183-441981B6-8480-4276-9D2C-21F06CC16140

P2860

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

http://www.wikidata.org/entity/Q34079631

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Anti-human leukocyte antigen a ...... apy after lung transplantation

@ast

Anti-human leukocyte antigen a ...... apy after lung transplantation

@en

Anti-human leukocyte antigen a ...... apy after lung transplantation

@nl

type

label

Anti-human leukocyte antigen a ...... apy after lung transplantation

@ast

Anti-human leukocyte antigen a ...... apy after lung transplantation

@en

Anti-human leukocyte antigen a ...... apy after lung transplantation

@nl

prefLabel

Anti-human leukocyte antigen a ...... apy after lung transplantation

@ast

Anti-human leukocyte antigen a ...... apy after lung transplantation

@en

Anti-human leukocyte antigen a ...... apy after lung transplantation

@nl

P1433

Q34079631-06919A9C-2483-42E4-B848-B6E292CE24C7

P1476

Q34079631-B3D6DC60-C58D-452A-B5A6-E44B8BB836F1

P2093

Q34079631-287B5603-DD66-4086-8710-B176E06D829B

Q34079631-3E7E8906-FD55-4B70-A215-9CA788CD9392

Q34079631-4B7139F3-3361-4781-957D-33E0DCE0A683

Q34079631-4C439C48-E811-4776-9C0F-1BA792F95D05

Q34079631-501A3F5E-8F28-49DE-8F32-0A64182841F6

Q34079631-A9345D90-9094-411F-B570-563D0E51FD1F

Q34079631-FBC7D0C5-B2C4-481E-9C10-3835FBEF42BE

P2860

Q34079631-0889581B-A032-452B-BDEB-9F719E2AF053

Q34079631-2A5047CC-1AEF-42A7-AC13-5D1A07411B0E

Q34079631-49B59637-677C-4E18-8E48-5F14AABB0CA7

Q34079631-69F68EF1-418D-4542-913E-EEDE11095973

Q34079631-974EE735-6689-42DC-B7F1-839108D7F89D

Q34079631-AD40375D-41E8-4244-9D61-DA2E4414C2EE

Q34079631-BB18B56E-5349-4D5D-BED7-1F955A0DF682

Q34079631-D7CAF7C5-C365-48FA-A2E8-10FC1E854C0A

Q34079631-E60B6FA0-FE41-4C6C-A1AC-15749A0E1E6F

Q34079631-F13F78D8-79E9-4568-B034-3890405C5E52

P304

Q34079631-6AFC6F48-FE6B-40B6-B075-8E4A3FA0CA3B

P31

Q34079631-DFF29E6C-5668-46FC-8450-D20326E01415

P356

Q34079631-A35E83B0-A840-4160-BF6A-6430A62BC090

P433

Q34079631-2FB4A7C3-4D36-4B3B-8B42-AF82F3C8D721

P478

Q34079631-0009C7D1-D837-4AB4-99AF-9FEB40111A66

P577

Q34079631-FE3C0F93-1CC4-43CA-9F31-670A645D5C32

P5875

Q34079631-1EA55EA5-78B7-444A-9EB4-6185B302933E

P698

Q34079631-8243169E-A5CE-4A7D-A8DE-0DC6804D078C

P921

Q34079631-7590FD21-6201-4295-A10B-84EFBF560626

Q34079631-D548797F-4CF5-4D8E-B6BB-97D6BED84694

P932

Q34079631-6EF0DE98-E4FC-4B20-ABEF-3CD6E8C85C8A

P356

J.HEALUN.2010.05.006

P1433

The Journal of Heart and Lung Transplantation

P1476

Anti-human leukocyte antigen a ...... apy after lung transplantation

@en

P2093

Aviva A Aloush

http://www.w3.org/2001/XMLSchema#string

Bryan F Meyers

http://www.w3.org/2001/XMLSchema#string

Elbert P Trulock

http://www.w3.org/2001/XMLSchema#string

G Alexander Patterson

http://www.w3.org/2001/XMLSchema#string

Ramsey R Hachem

http://www.w3.org/2001/XMLSchema#string

Roger D Yusen

http://www.w3.org/2001/XMLSchema#string

Thalachallour Mohanakumar

http://www.w3.org/2001/XMLSchema#string

P2860

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Review article: Luminex technology for HLA antibody detection in organ transplantation.

Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome.

Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.

Lung transplant outcomes in white and African American recipients: special focus on acute and chronic rejection.

Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.

Induction of obliterative airway disease by anti-HLA class I antibodies.

P304

973-980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HEALUN.2010.05.006

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44682829

http://www.w3.org/2001/XMLSchema#string

P698

20558084

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

P932

2926224

http://www.w3.org/2001/XMLSchema#string